Stay updated on Lazertinib Combination in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lazertinib Combination in NSCLC Clinical Trial page.

Latest updates to the Lazertinib Combination in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays Revision: v3.6.1, indicating a minor build update to the study details page. No substantive study information appears to be altered.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check22 days agoChange DetectedThe study record revision was updated from v3.5.4 to v3.5.5, indicating a small maintenance update to the record's metadata and backend data. This update does not imply changes to the described study details.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page revision has been updated from v3.5.3 to v3.5.4, indicating a small platform or content-management update rather than a change to the study information.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded a Publications entry for the CHRYSALIS-2 Cohort A paper with full author details. Corrected the Köln collaborator location by replacing the misspelled entry with the proper 'Kliniken der Stadt Köln gGmbH, Krankenhaus Köln-Mehrheim' and removed the erroneous version.SummaryDifference0.3%

- Check58 days agoChange DetectedThe page's revision line was updated from v3.5.2 to v3.5.3. This indicates a new revision of the page content.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page footer revision label was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Lazertinib Combination in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lazertinib Combination in NSCLC Clinical Trial page.